Knocking down RNF144A-AS1 also significantly inhibited the EMT, a key contributor to tumor invasion and metastasis, by inducing the expression of epithelial markers (E-cadherin and ZO-1) and suppressing the expression of mesenchymal markers (N-cadherin and Vimentin). The gene discussed is CDH2; the disease is neoplasm.